JP2019504030A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019504030A5 JP2019504030A5 JP2018532747A JP2018532747A JP2019504030A5 JP 2019504030 A5 JP2019504030 A5 JP 2019504030A5 JP 2018532747 A JP2018532747 A JP 2018532747A JP 2018532747 A JP2018532747 A JP 2018532747A JP 2019504030 A5 JP2019504030 A5 JP 2019504030A5
- Authority
- JP
- Japan
- Prior art keywords
- zika virus
- virus vaccine
- vaccine
- seq
- sucrose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15202585.4 | 2015-12-23 | ||
| EP15202585 | 2015-12-23 | ||
| EP16161068.8 | 2016-03-18 | ||
| EP16161068 | 2016-03-18 | ||
| EP16176025 | 2016-06-23 | ||
| EP16176049 | 2016-06-23 | ||
| EP16176025.1 | 2016-06-23 | ||
| EP16176049.1 | 2016-06-23 | ||
| EP16182845.4 | 2016-08-04 | ||
| EP16182845 | 2016-08-04 | ||
| PCT/EP2016/082664 WO2017109225A1 (en) | 2015-12-23 | 2016-12-23 | Zika virus vaccine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019504030A JP2019504030A (ja) | 2019-02-14 |
| JP2019504030A5 true JP2019504030A5 (enExample) | 2019-12-26 |
| JP6949027B2 JP6949027B2 (ja) | 2021-10-20 |
Family
ID=57821924
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018532747A Active JP6949027B2 (ja) | 2015-12-23 | 2016-12-23 | ジカウイルスワクチン |
Country Status (19)
| Country | Link |
|---|---|
| US (14) | US11331382B2 (enExample) |
| EP (9) | EP3393508B9 (enExample) |
| JP (1) | JP6949027B2 (enExample) |
| KR (1) | KR102950500B1 (enExample) |
| CN (2) | CN108697785B (enExample) |
| AU (1) | AU2016375338B2 (enExample) |
| BR (1) | BR112018012873A2 (enExample) |
| CA (1) | CA3009278A1 (enExample) |
| DK (1) | DK3393510T4 (enExample) |
| ES (4) | ES2950887T3 (enExample) |
| FI (1) | FI3393510T4 (enExample) |
| HR (1) | HRP20230273T1 (enExample) |
| HU (1) | HUE061679T2 (enExample) |
| LT (1) | LT3393510T (enExample) |
| MX (1) | MX2018007627A (enExample) |
| PL (1) | PL3393510T3 (enExample) |
| SG (1) | SG11201805120YA (enExample) |
| SI (1) | SI3393510T1 (enExample) |
| WO (6) | WO2017109224A1 (enExample) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9895437B2 (en) | 2012-04-18 | 2018-02-20 | Valneva Austria Gmbh | Aluminum compounds for use in therapeutics and vaccines |
| CA2992531C (en) * | 2015-07-16 | 2023-09-26 | Bharat Biotech International Limited | Vaccine compositions |
| ES2950887T3 (es) | 2015-12-23 | 2023-10-16 | Valneva Austria Gmbh | Purificación del Virus Zika |
| WO2018009604A1 (en) * | 2016-07-08 | 2018-01-11 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Chimeric dengue/zika viruses live-attenuated zika virus vaccines |
| CN118662621A (zh) | 2017-09-21 | 2024-09-20 | 瓦尔尼瓦公司 | 包含免疫原性屈公病毒chikv-delta5nsp3的医药组成物的制备方法 |
| MY202505A (en) * | 2017-11-03 | 2024-05-01 | Takeda Vaccines Inc | Zika vaccines and immunogenic compositions, and methods of using the same |
| CN107988239B (zh) * | 2017-11-29 | 2021-03-19 | 南方医科大学 | 一种寨卡病毒的重组基因及其制备方法和应用 |
| SG11202003975WA (en) | 2017-11-30 | 2020-06-29 | Takeda Vaccines Inc | Method for inactivating zika virus and related methods |
| CN107904215B (zh) * | 2017-12-27 | 2021-07-27 | 华农（肇庆）生物产业技术研究院有限公司 | 一种禽流感病毒的全悬浮培养方法 |
| CN110156880B (zh) * | 2018-02-13 | 2022-12-16 | 吴夙钦 | 兹卡病毒疫苗组合物及其应用 |
| TWI658848B (zh) * | 2018-02-13 | 2019-05-11 | National Tsing Hua University | 茲卡病毒疫苗組合物及其應用 |
| CN119488586A (zh) | 2018-03-26 | 2025-02-21 | 勃林格殷格翰动物保健美国有限公司 | 制备免疫原性组合物的方法 |
| CN108676780B (zh) * | 2018-07-24 | 2021-08-10 | 华中农业大学 | 一种高效分离猪肠道冠状病毒的方法 |
| CN109337876A (zh) * | 2018-10-15 | 2019-02-15 | 北京世纪元亨动物防疫技术有限公司 | 一种猪流行性腹泻病毒的纯化方法 |
| JP7463366B2 (ja) | 2018-11-20 | 2024-04-08 | タケダ ワクチン，インコーポレイテッド | 新規の抗ジカウイルス抗体及びその使用 |
| CN109627297B (zh) * | 2018-12-29 | 2022-06-14 | 复旦大学 | 来自寨卡病毒e蛋白的中和表位及其应用 |
| AU2020211990A1 (en) * | 2019-01-22 | 2021-08-12 | 2Seventy Bio, Inc. | Methods and systems for manufacturing viral vectors |
| AU2020269164B2 (en) * | 2019-05-08 | 2024-04-04 | Takeda Vaccines, Inc. | Inactivated virus compositions and Zika vaccine formulations |
| WO2021028406A1 (en) | 2019-08-09 | 2021-02-18 | Valneva Se | Chikungunya vaccine formulations |
| CA3149932A1 (en) | 2019-08-09 | 2021-02-18 | Valneva Se | Single shot chikungunya virus vaccine |
| EP4028511A1 (en) | 2019-09-09 | 2022-07-20 | Valneva Austria GmbH | Inactivation process for viruses |
| KR102243295B1 (ko) * | 2019-11-15 | 2021-04-23 | 강원대학교산학협력단 | 지카바이러스의 외피 단백질을 포함하는 재조합 백신 조성물 |
| KR102365464B1 (ko) * | 2019-12-24 | 2022-02-22 | 강원대학교산학협력단 | 지카바이러스 재조합 서브유닛 백신의 개발 및 이의 제조방법 |
| US12521429B2 (en) | 2020-02-05 | 2026-01-13 | New York Blood Center, Inc. | Zika virus immunogenic compositions |
| EP3895729A1 (en) | 2020-03-01 | 2021-10-20 | Valneva Austria GmbH | Cpg-adjuvanted sars-cov-2 virus vaccine |
| JP2023515908A (ja) | 2020-03-01 | 2023-04-14 | ヴァルネヴァ・オーストリア・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | ＣｐＧアジュバント化ＳＡＲＳ－ＣｏＶ－２ウイルスワクチン |
| WO2021178306A1 (en) | 2020-03-01 | 2021-09-10 | Dynavax Technologies Corporation | Coronavirus vaccines comprising a tlr9 agonist |
| CA3173301A1 (en) * | 2020-03-03 | 2021-09-10 | Mayo Foundation For Medical Education And Research | Zika virus polypeptides |
| WO2021178877A1 (en) | 2020-03-06 | 2021-09-10 | The Colorado State University Research Foundation | Production of vaccines comprising inactivated sars-cov-2 viral particles |
| PY2126530A (es) | 2020-04-06 | 2022-09-12 | Valneva Austria Gmbh | VACUNA INACTIVADA CONTRA EL VIRUS DEL SARS-CoV-2 |
| WO2021236225A1 (en) | 2020-05-20 | 2021-11-25 | Takeda Vaccines, Inc. | Method for detection of zika virus specific antibodies |
| JP2023527169A (ja) | 2020-05-20 | 2023-06-27 | タケダ ワクチン，インコーポレイテッド | 抗原の効力を決定するための方法 |
| US20230324404A1 (en) | 2020-05-20 | 2023-10-12 | Takeda Vaccines, Inc. | Method for detection of zika virus specific antibodies |
| WO2023148256A1 (en) | 2022-02-02 | 2023-08-10 | Valneva Austria Gmbh | Inactivated sars-cov-2 virus vaccine |
| US20250381261A1 (en) * | 2022-02-09 | 2025-12-18 | Takeda Vaccines, Inc. | Zika vaccines and immunogenic compositions, and methods of using the same |
| WO2025099278A2 (en) * | 2023-11-08 | 2025-05-15 | Valneva Austria Gmbh | Immunogenic zika virus compositions and uses thereof |
| WO2026052881A1 (en) | 2024-09-09 | 2026-03-12 | Valneva Austria Gmbh | Chikungunya virus vaccine multidose formulation and use thereof in outbreaks |
| WO2026052882A1 (en) | 2024-09-09 | 2026-03-12 | Valneva Austria Gmbh | Yellow fever virus (yfv) compositions and production thereof |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US86061A (en) * | 1869-01-19 | Improved horse-power | ||
| DE122009000037I2 (de) * | 1997-08-28 | 2011-06-16 | Cheil Jedang Corp | Ein an vero-zellen angepasstes abgeschwächtes japanisches enzephalitis virus und ein impfstoff gegen japanische enzephalitis |
| WO2000014245A1 (en) * | 1998-09-02 | 2000-03-16 | The Government Of The United States Of America Represented By The Secretary, Department Of Health And Human Services | Dengue viruses that are replication defective in mosquitos for use as vaccines |
| US6767699B2 (en) | 2000-05-31 | 2004-07-27 | Chiron Corporation | Method for the quantitation of alphavirus replicon particles |
| WO2002074963A1 (en) * | 2001-03-16 | 2002-09-26 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Healt | Dengue viruses that are replication defective in mosquitos for use as vaccines |
| WO2002089840A1 (en) * | 2001-05-10 | 2002-11-14 | The Regents Of The University Of California | Recombinant bicistronic flaviviruses and methods of use thereof |
| AU2004224746B2 (en) | 2003-03-24 | 2009-04-23 | Valneva Austria Gmbh | Improved vaccines |
| BRPI0716145B1 (pt) * | 2006-09-01 | 2021-06-22 | Bharat Biotech International Limited | Composição de vacina e método para preparar uma composição de vacina para o vírus chikungunya |
| WO2009048633A2 (en) | 2007-10-11 | 2009-04-16 | The Board Of Regents Of The University Of Texas System | Chimeric chikungunya virus and uses thereof |
| WO2009129616A1 (en) * | 2008-04-21 | 2009-10-29 | Tissue Regeneration Therapeutics, Inc. | Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents |
| CN102317308A (zh) * | 2008-11-26 | 2012-01-11 | 美国国有健康与人类服务部 | 类病毒组合物颗粒及其使用方法 |
| WO2010085358A2 (en) * | 2009-01-23 | 2010-07-29 | The Board Of Regents Of The University Of Texas System | Flaviviruses expressing the prm, e, and ns1 proteins of other flaviviruses and uses thereof |
| US8765148B2 (en) | 2010-02-19 | 2014-07-01 | Valneva Austria Gmbh | 1C31 nanoparticles |
| EP4400115A3 (en) | 2011-12-06 | 2024-10-23 | Valneva Austria GmbH | Aluminium compounds for use in therapeutics and vaccines |
| US9895437B2 (en) | 2012-04-18 | 2018-02-20 | Valneva Austria Gmbh | Aluminum compounds for use in therapeutics and vaccines |
| WO2016145149A1 (en) * | 2015-03-11 | 2016-09-15 | The United States Of America, As Represented By The Secretary Of The Army, On Behalf Of The Walter Reed Army Institute Of Research | Combination purified inactivated vaccine for flaviviruses |
| CA2992531C (en) | 2015-07-16 | 2023-09-26 | Bharat Biotech International Limited | Vaccine compositions |
| ES2950887T3 (es) | 2015-12-23 | 2023-10-16 | Valneva Austria Gmbh | Purificación del Virus Zika |
| CN105749268B (zh) * | 2016-04-11 | 2020-09-11 | 北京科兴中维生物技术有限公司 | 一种灭活的寨卡病毒疫苗 |
| CN118662621A (zh) | 2017-09-21 | 2024-09-20 | 瓦尔尼瓦公司 | 包含免疫原性屈公病毒chikv-delta5nsp3的医药组成物的制备方法 |
-
2016
- 2016-12-23 ES ES16826741T patent/ES2950887T3/es active Active
- 2016-12-23 SG SG11201805120YA patent/SG11201805120YA/en unknown
- 2016-12-23 WO PCT/EP2016/082663 patent/WO2017109224A1/en not_active Ceased
- 2016-12-23 EP EP16826741.7A patent/EP3393508B9/en active Active
- 2016-12-23 PL PL16828746.4T patent/PL3393510T3/pl unknown
- 2016-12-23 CN CN201680074939.XA patent/CN108697785B/zh active Active
- 2016-12-23 ES ES16826739T patent/ES2976311T3/es active Active
- 2016-12-23 DK DK16828746.4T patent/DK3393510T4/da active
- 2016-12-23 WO PCT/EP2016/082664 patent/WO2017109225A1/en not_active Ceased
- 2016-12-23 KR KR1020187017319A patent/KR102950500B1/ko active Active
- 2016-12-23 EP EP16828746.4A patent/EP3393510B2/en active Active
- 2016-12-23 EP EP16826739.1A patent/EP3393506B1/en active Active
- 2016-12-23 AU AU2016375338A patent/AU2016375338B2/en active Active
- 2016-12-23 JP JP2018532747A patent/JP6949027B2/ja active Active
- 2016-12-23 LT LTEPPCT/EP2016/082664T patent/LT3393510T/lt unknown
- 2016-12-23 ES ES16828745T patent/ES2973267T3/es active Active
- 2016-12-23 US US16/060,054 patent/US11331382B2/en active Active
- 2016-12-23 EP EP16828745.6A patent/EP3393509B1/en active Active
- 2016-12-23 US US16/063,007 patent/US10639365B2/en active Active
- 2016-12-23 WO PCT/EP2016/082667 patent/WO2017109228A1/en not_active Ceased
- 2016-12-23 HU HUE16828746A patent/HUE061679T2/hu unknown
- 2016-12-23 BR BR112018012873-2A patent/BR112018012873A2/pt active Search and Examination
- 2016-12-23 SI SI201631676T patent/SI3393510T1/sl unknown
- 2016-12-23 FI FIEP16828746.4T patent/FI3393510T4/fi active
- 2016-12-23 EP EP23219512.3A patent/EP4357355A3/en not_active Withdrawn
- 2016-12-23 WO PCT/EP2016/082666 patent/WO2017109227A1/en not_active Ceased
- 2016-12-23 CA CA3009278A patent/CA3009278A1/en active Pending
- 2016-12-23 WO PCT/EP2016/082662 patent/WO2017109223A1/en not_active Ceased
- 2016-12-23 WO PCT/EP2016/082668 patent/WO2017109229A1/en not_active Ceased
- 2016-12-23 US US15/781,959 patent/US10660950B2/en active Active
- 2016-12-23 CN CN202210678575.3A patent/CN115381934A/zh active Pending
- 2016-12-23 US US15/781,825 patent/US10744194B2/en active Active
- 2016-12-23 HR HRP20230273TT patent/HRP20230273T1/hr unknown
- 2016-12-23 EP EP23152481.0A patent/EP4218807A3/en active Pending
- 2016-12-23 US US16/062,245 patent/US10537630B2/en active Active
- 2016-12-23 EP EP23175136.3A patent/EP4253403A3/en active Pending
- 2016-12-23 EP EP16826740.9A patent/EP3393507B1/en active Active
- 2016-12-23 MX MX2018007627A patent/MX2018007627A/es unknown
- 2016-12-23 ES ES16828746T patent/ES2941967T3/es active Active
- 2016-12-23 EP EP24159155.1A patent/EP4393938A3/en active Pending
-
2019
- 2019-12-04 US US16/702,764 patent/US11207397B2/en active Active
-
2020
- 2020-03-10 US US16/813,862 patent/US11219681B2/en active Active
- 2020-04-06 US US16/840,760 patent/US11406700B2/en active Active
- 2020-07-13 US US16/927,086 patent/US11524064B2/en active Active
-
2021
- 2021-12-13 US US17/548,721 patent/US12005111B2/en active Active
-
2022
- 2022-07-06 US US17/811,059 patent/US12214033B2/en active Active
-
2023
- 2023-03-06 US US18/178,638 patent/US11951163B2/en active Active
- 2023-06-14 US US18/334,497 patent/US12102673B2/en active Active
-
2024
- 2024-08-09 US US18/799,291 patent/US20250018023A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11207397B2 (en) | Virus purification | |
| JP5129805B2 (ja) | 細胞培養物から精製水疱性口内炎ウイルスを単離するための精製プロセス | |
| TW202203967A (zh) | 不活化ＳＡＲＳ—ＣｏＶ—２病毒疫苗 | |
| US20240293531A1 (en) | Inactivated sars-cov-2 virus vaccine | |
| JPWO2000020565A1 (ja) | 日本脳炎ウイルス群感染症に対する不活化ワクチンのための増強免疫原およびその製造方法 | |
| HK40103263A (en) | Virus purification | |
| HK40106064A (en) | Virus purification | |
| HK1261326B (en) | Virus purification | |
| HK1261326A1 (en) | Virus purification | |
| HK1261562A1 (en) | Virus purification | |
| HK1261562B (en) | Virus purification | |
| AU2007221746A1 (en) | Improvements in virus production |